HCPLive spoke to a healthcare expert who gave his thoughts on the Reagan Udall Foundation for the FDA’s recent meeting to discuss advancing treatments for PTSD. Last Friday, on September 6, 2024, the Reagan Udall Foundation for the US Food and Drug Administration (FDA) hosted the public meeting, “Advancing Treatments for Post-Traumatic Stress Disorder,” for federal partners and stakeholders to share their views on the unmet need in PTSD therapies and current efforts to fill this need.